Knock-down mouse, a novel gene engineering mouse for use as a disease model
Knock-down mouse, a novel gene engineering mouse for use as a disease model
批准号:
11480251
负责人:
OHNISHI Yasuyuki
金额:
$9.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
在本研究中,我们试图构建一种新型的基因工程小鼠,该小鼠包含四环素调控基因表达系统(Tet-OFF和Tet-ON)和由该开关系统驱动的利比赛酶基因。首先,我们构建了一个抗胰岛素核酶,并使用合成的胰岛素RNA和核酶进行体外切割实验。该核酶对RNA具有体外裂解活性。该核酶在M6胰岛素瘤细胞转染系统中也显示出抗胰岛素活性。制备了用于血管内皮生长因子(VEGF)和活化K-ras基因RNA的核酶,并在细胞转化和体外裂解实验系统中显示了裂解活性。此外,转染抗vegf或抗k -ras核酶的肿瘤细胞在裸鼠中的致瘤活性降低。利用Tet-OFF和Tet-ON系统分别建立了转染rusiferase基因的转基因小鼠。老鼠很兴奋。
英文摘要
In this research, we attempt to create a novel gene engineering mouse which contains the target gene expression-switch such as tetracycline regulated gene expression system (Tet-OFF and Tet-ON) and a gene for ribizyme driven by the switch system. First, we constructed an anti-insulin ribozyme, and examined in vitro cleaving assay using synthesized insulin RNA and the ribozyme. The ribozyme showed in vitro cleavage activity to the RNA.The ribozyme also showed anti-insulin activity in M6 insulinoma cell transfectant system. Another ribozymes were created for VEGF (vascular endotherial growth factor) and activated K-ras gene RNA, and they showed cleaving activity in cell transformant and in vitro cleavage assay system.Also, tumor cells transfected by the anti-VEGF or anti-K-ras ribozyme showed reduced tumorigenic activity in nude mouse. Transgenic mice for rusiferase gene driven by the Tet-OFF and Tet-ON system were created. The mice were under exanimation.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Okamoto, K., Oshika, K., Fukushima, Y., Ohnishi, Y., Tokunaga, T., Tomii, Y., Kijima, H., Yamazaki H., Ueyama, Y., Tamaoki, N.and Nakamura, M.: "Xenografts of solid tumors frequently express cellular-associated isoform of vascular endothelial growth facto
冈本 K.、大鹿 K.、福岛 Y.、大西 Y.、德永 T.、富井 Y.、木岛 H.、山崎 H.、上山 Y.、玉兴 N. 和中村
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ueyama, Y., Abe, Y., Ohnishi, Y., Sawa, N., Hatanaka, H., Handa, A., Tokuda, Y., Yamazaki, H., Kijima, H., Tamaoki, N.and Nakamura, M.: "In vivo chemosensitivity of human malignant cystosarcoma phyllodes xenograft."Oncol.Rep.. 7. 257-260 (2000)
上山 Y.、阿部 Y.、大西 Y.、泽 N.、畑中 H.、半田 A.、德田 Y.、山崎 H.、木岛 H.、玉木 N. 和
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Oshika,Y: "Ribozyme approach to downregulate vascular endothelial growth factor (VEGF) 189 expression in non-small cell lung cancer (NSCLC)"Eur.J.Cancer. 36. 2390-2396 (2000)
Oshika,Y:“核酶方法下调非小细胞肺癌 (NSCLC) 中血管内皮生长因子 (VEGF) 189 的表达”Eur.J.Cancer。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ohnishi, Y., Arai, T., Koshirakawa, M., Horii, N., Nakajo, S., Urano, K., Usui, T., Tamaoki, N., and Ueyama, Y.: "Induction of drug metabolism-related enzymes by methylcholanthrene and phenobarbital in transgenic mice carrieng human prototype c-Ha-ras gen
Ohnishi, Y.、Arai, T.、Koshirakawa, M.、Horii, N.、Nakajo, S.、Urano, K.、Usui, T.、Tamaoki, N. 和 Ueyama, Y.:“药物的诱导
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tokunaga,T.: "Ribozyme-mediated inactivation of mutant K-ras oncogene in a colon cancer cell line"Br.J.Cancer. 83. 833-839 (2000)
Tokunaga,T.:“核酶介导的结肠癌细胞系中突变 K-ras 癌基因的失活”Br.J.Cancer。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 16 条
Establishment of human tumor xenotransplantation models as a pre-clinical assisting tool for translational research
-
批准号:13480283
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.26万
-
财政年份:2001
-
负责人:OHNISHI Yasuyuki
-
依托单位:
Studies on in vivo evaluation system of treatment for cancer prevention and progression using cancer prone gene-engineered mice
-
批准号:12558097
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.45万
-
财政年份:2000
-
负责人:OHNISHI Yasuyuki
-
依托单位:
Improvement of human tumor xenograft-mouse model as a preclinical evaluation system of new drugs discovered and developed by the novel strategy against cancer
-
批准号:08458278
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$1.73万
-
财政年份:1996
-
负责人:OHNISHI Yasuyuki
-
依托单位:
A new approach for prediction of clinical efficacy of anticancer drugs based on toxicokinetic and pharmacokinetic analysis
-
批准号:07558117
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$5.31万
-
财政年份:1995
-
负责人:OHNISHI Yasuyuki
-
依托单位:
Studies on genetic and microbiologicail quality of human tumor xenografts lines as a tool for animal experiments
-
批准号:05454690
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.52万
-
财政年份:1993
-
负责人:OHNISHI Yasuyuki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
增强子在小鼠早期胚胎细胞命运决定中的功能和调控机制研究
-
批准号:82371668
-
项目类别:面上项目
-
资助金额:52.00万元
-
批准年份:2023
-
负责人:乔云波
-
依托单位:
睾丸特异性新基因TSC29的表达调控机制及其功能研究
-
批准号:81170613
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2011
-
负责人:唐爱发
-
依托单位:
mir-125b在1型糖尿病自身免疫性胰岛炎中的作用及机制研究
-
批准号:30901627
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2009
-
负责人:韩蓓
-
依托单位:
转录调控中起作用的细胞周期激酶的鉴定及其作用机制研究
-
批准号:30970625
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2009
-
负责人:李沁桐
-
依托单位:
NDV7793株刺激小鼠NK细胞TRAIL表达及杀伤肝癌细胞的实验研究
-
批准号:30860328
-
项目类别:地区科学基金项目
-
资助金额:25.0万元
-
批准年份:2008
-
负责人:樊晓晖
-
依托单位:
大小鼠卵泡体外毒性试验系统的建立
-
批准号:30571587
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2005
-
负责人:张天宝
-
依托单位: